These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25692015)

  • 1. Pharmacological and pharmacokinetic properties of JNJ-40411813, a positive allosteric modulator of the mGlu2 receptor.
    Lavreysen H; Ahnaou A; Drinkenburg W; Langlois X; Mackie C; Pype S; Lütjens R; Le Poul E; Trabanco AA; Nuñez JM
    Pharmacol Res Perspect; 2015 Feb; 3(1):e00096. PubMed ID: 25692015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of JNJ-40068782, a new potent, selective, and systemically active positive allosteric modulator of the mGlu2 receptor and its radioligand [3H]JNJ-40068782.
    Lavreysen H; Langlois X; Ahnaou A; Drinkenburg W; te Riele P; Biesmans I; Van der Linden I; Peeters L; Megens A; Wintmolders C; Cid JM; Trabanco AA; Andrés JI; Dautzenberg FM; Lütjens R; Macdonald G; Atack JR
    J Pharmacol Exp Ther; 2013 Sep; 346(3):514-27. PubMed ID: 23766542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical evaluation of the antipsychotic potential of the mGlu2-positive allosteric modulator JNJ-40411813.
    Lavreysen H; Langlois X; Donck LV; Nuñez JM; Pype S; Lütjens R; Megens A
    Pharmacol Res Perspect; 2015 Mar; 3(2):e00097. PubMed ID: 25692027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mGlu2 Receptor Agonism, but Not Positive Allosteric Modulation, Elicits Rapid Tolerance towards Their Primary Efficacy on Sleep Measures in Rats.
    Ahnaou A; Lavreysen H; Tresadern G; Cid JM; Drinkenburg WH
    PLoS One; 2015; 10(12):e0144017. PubMed ID: 26658273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanism of positive allosteric modulation of the metabotropic glutamate receptor 2 by JNJ-46281222.
    Doornbos ML; Pérez-Benito L; Tresadern G; Mulder-Krieger T; Biesmans I; Trabanco AA; Cid JM; Lavreysen H; IJzerman AP; Heitman LH
    Br J Pharmacol; 2016 Feb; 173(3):588-600. PubMed ID: 26589404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2.
    Lundström L; Bissantz C; Beck J; Dellenbach M; Woltering TJ; Wichmann J; Gatti S
    Neuropharmacology; 2016 Dec; 111():253-265. PubMed ID: 27590915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of mGlu
    Metcalf CS; Klein BD; Smith MD; Pruess T; Ceusters M; Lavreysen H; Pype S; Van Osselaer N; Twyman R; White HS
    Epilepsia; 2017 Mar; 58(3):484-493. PubMed ID: 28166368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprint of Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2.
    Lundström L; Bissantz C; Beck J; Dellenbach M; Woltering TJ; Wichmann J; Gatti S
    Neuropharmacology; 2017 Mar; 115():115-127. PubMed ID: 28216000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translational neurophysiological markers for activity of the metabotropic glutamate receptor (mGluR2) modulator JNJ-40411813: Sleep EEG correlates in rodents and healthy men.
    Ahnaou A; de Boer P; Lavreysen H; Huysmans H; Sinha V; Raeymaekers L; Van De Casteele T; Cid JM; Van Nueten L; Macdonald GJ; Kemp JA; Drinkenburg WH
    Neuropharmacology; 2016 Apr; 103():290-305. PubMed ID: 26686390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of [
    Kang MS; Hamadjida A; Bédard D; Nuara SG; Gourdon JC; Frey S; Aliaga A; Ross K; Hopewell R; Bdair H; Mathieu A; Tardif CL; Soucy JP; Massarweh G; Rosa-Neto P; Huot P
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Sep; 396(9):2095-2103. PubMed ID: 36928556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of systemically active metabotropic glutamate subtype-2 and -3 (mGlu2/3) receptor positive allosteric modulators (PAMs): pharmacological characterization and assessment in a rat model of cocaine dependence.
    Dhanya RP; Sheffler DJ; Dahl R; Davis M; Lee PS; Yang L; Nickols HH; Cho HP; Smith LH; D'Souza MS; Conn PJ; Der-Avakian A; Markou A; Cosford ND
    J Med Chem; 2014 May; 57(10):4154-72. PubMed ID: 24735492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro pharmacological and rat pharmacokinetic characterization of LY3020371, a potent and selective mGlu
    Witkin JM; Ornstein PL; Mitch CH; Li R; Smith SC; Heinz BA; Wang XS; Xiang C; Carter JH; Anderson WH; Li X; Broad LM; Pasqui F; Fitzjohn SM; Sanger HE; Smith JL; Catlow J; Swanson S; Monn JA
    Neuropharmacology; 2017 Mar; 115():100-114. PubMed ID: 26748052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent and selective pharmacodynamic synergy between the metabotropic glutamate receptor subtype 2-positive allosteric modulator JNJ-46356479 and levetiracetam in the mouse 6-Hz (44-mA) model.
    Metcalf CS; Klein BD; Smith MD; Ceusters M; Lavreysen H; Pype S; Van Osselaer N; Twyman R; White HS
    Epilepsia; 2018 Mar; 59(3):724-735. PubMed ID: 29360159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of 1-butyl-3-chloro-4-(4-phenyl-1-piperidinyl)-(1H)-pyridone (JNJ-40411813): a novel positive allosteric modulator of the metabotropic glutamate 2 receptor.
    Cid JM; Tresadern G; Duvey G; Lütjens R; Finn T; Rocher JP; Poli S; Vega JA; de Lucas AI; Matesanz E; Linares ML; Andrés JI; Alcazar J; Alonso JM; Macdonald GJ; Oehlrich D; Lavreysen H; Ahnaou A; Drinkenburg W; Mackie C; Pype S; Gallacher D; Trabanco AA
    J Med Chem; 2014 Aug; 57(15):6495-512. PubMed ID: 25032784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mGlu(2) receptor-mediated modulation of conditioned avoidance behavior in rats.
    Megens AA; Hendrickx HM; Hens KA; Talloen WJ; Lavreysen H
    Eur J Pharmacol; 2014 Mar; 727():130-9. PubMed ID: 24486391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of the neurophysiological profile of group II metabotropic glutamate receptor activators and diazepam: effects on hippocampal and cortical EEG patterns in rats.
    Siok CJ; Cogan SM; Shifflett LB; Doran AC; Kocsis B; Hajós M
    Neuropharmacology; 2012 Jan; 62(1):226-36. PubMed ID: 21791219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and preliminary studies of
    Zhang X; Zhang Y; Chen Z; Shao T; Van R; Kumata K; Deng X; Fu H; Yamasaki T; Rong J; Hu K; Hatori A; Xie L; Yu Q; Ye W; Xu H; Sheffler DJ; Cosford NDP; Shao Y; Tang P; Wang L; Zhang MR; Liang SH
    Theranostics; 2020; 10(24):11178-11196. PubMed ID: 33042277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Pharmacology and Binding of mGlu
    O'Brien DE; Shaw DM; Cho HP; Cross AJ; Wesolowski SS; Felts AS; Bergare J; Elmore CS; Lindsley CW; Niswender CM; Conn PJ
    Mol Pharmacol; 2018 May; 93(5):526-540. PubMed ID: 29545267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-[5-(3,4-Dichloro-phenyl)-1-(4-methoxy-phenyl)-1H-pyrazol-3-yl]-2-m-tolyl-propionate (JNJ-17156516), a novel, potent, and selective cholecystokinin 1 receptor antagonist: in vitro and in vivo pharmacological comparison with dexloxiglumide.
    Morton MF; Barrett TD; Yan W; Freedman JM; Lagaud G; Prendergast CE; Moreno V; Pyati J; Figueroa K; Li L; Wu X; Rizzolio M; Breitenbucher JG; McClure K; Shankley NP
    J Pharmacol Exp Ther; 2007 Nov; 323(2):562-9. PubMed ID: 17684117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurophysiologic and antipsychotic profiles of TASP0433864, a novel positive allosteric modulator of metabotropic glutamate 2 receptor.
    Hiyoshi T; Marumo T; Hikichi H; Tomishima Y; Urabe H; Tamita T; Iida I; Yasuhara A; Karasawa J; Chaki S
    J Pharmacol Exp Ther; 2014 Dec; 351(3):642-53. PubMed ID: 25277141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.